Skip to main content

Elana Rosenthal, MD

Academic Title:

Assistant Professor

Primary Appointment:

Medicine

Additional Title:

Co-Director, DC Partnership for HIV/AIDS Progress Hepatitis Clinical Research Program

Phone (Primary):

240-367-4157

Fax:

301-480-4838

Education and Training

BA, Yale University, 2006

MD, University of Chicago Pritzker School of Medicine, 2010

Residency - Internal Medicine, Beth Israel Deaconess Medical Center, 2013

Fellowship - Infectious Diseases, Beth Israel Deaconess Medical Center, 2015

Biosketch

I am a physician specializing in infectious diseases, and serve as co-director of the DC Partnership for HIV/AIDS Progress Hepatitis Clinical Research Program. My research and clinical care focus on the intersection of opioid use disorder and infectious diseases, and I practice in community based sites in Washington, DC and Baltimore.

Research/Clinical Keywords

HCV, HIV, PWID

Highlighted Publications

 

Rosenthal ES, Karchmer AW, Theisen-Toupal J, Araujo R, Rowley C. Suboptimal Addiction Interventions for Patients Hospitalized with Injection Drug Use Associated Infective Endocarditis. Am J Med. May;129(5):481-5.

Rosenthal ES, Polis MA, Kottilil S. Sofosbuvir and Ledipasvir for HIV/HCV Co-infected Patients. Expert Opin Pharmacother. 2016 Apr;17(5):743-9.

Theisen-Toupal J, Rosenthal ES, Rowley CF. Reimagining long-term antibiotics for persons who inject drugs: time to shift the status quo? J Hosp Med. 2016 Apr 4.

Rosenthal ES, Graham C. Price and Affordability of Direct-Acting Antiviral Regimens for Hepatitis C Virus. Infectious Agents and Cancer. 2016 May 16;11:24.

Theisen-Toupal J, Ronan MV, Moore A, Rosenthal ES. Inpatient Management of Opioid Use Disorder: A Review for Hospitalists. J Hosp Med. 2017 May;12(5):369-374. doi: 10.12788/jhm.2731. PMID: 28459909

Rosenthal ES, Kattakuzhy S, Kottilil S. Time to end treatment restrictions for people with hepatitis C who inject drugs. Lancet Gastroenterol Hepatol. 2018 Jan 5. pii: S2468-1253(18)30001-3. doi: 10.1016/S2468-1253(18)30001-3. [Epub ahead of print] PMID: 29310927

Kattakuzhy S, Gross C, Emmanuel B, Teferi G, Jenkins V, Silk R, Akoth E, Thomas A, Ahmed C, Espinosa M, Price A, Rosenthal E, Tang L, Wilson E, Bentzen S, Masur H, Kottilil S; and the ASCEND Providers. Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Randomized Clinical Trial. Ann Intern Med. 2017 Sep 5;167(5):311-318. doi: 10.7326/M17-0118. Epub 2017 Aug 8. PMID: 28785771

Leahy PA, Lasalvia M, Rosenthal ES, Karchmer AW, Rowley CF. High morbidity and mortality among patients with sentinel admission for injection drug use-related infective endocarditis. Open Forum Infectious Diseases. 2019 Mar 1;6(4):ofz089. doi: 10.1093/ofid/ofz089. eCollection 2019 Apr.

Schwetz T, Calder T, Rosenthal E, Kattakuzhy S, Fauci AF. Opioids and Infectious Diseases: A Converging Public Health Crisis. Journal of Infectious Diseases. 2019 Jul 2;220(3):346-349. doi: 10.1093/infdis/jiz133.

Rosenthal ES, et al. Concurrent Initiation of HCV and OUD Treatment in People who Inject Drugs. Clinical Infectious Diseases. [Accepted]

Li A, Rosenthal E, Rapoport A, Rowley CF. Opioid Use Disorder and Infectious Complications in Persons Who Inject Drugs. International Anesthesiology Clinics. [Accepted]

Clinical Specialty Details

Infectious Diseases

Links of Interest